← Leaderboards
Kasia Joanna Lipska
Yale University
$3,105,227
Attributed
$3,913,411
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,913,411 · 7
By mechanism
R01$2,102,176 · 3
K23$777,933 · 1
R21$466,802 · 1
R56$400,000 · 1
R03$166,500 · 1
Top collaborators
- Victor Manuel Montori2 shared
- Andrew John Karter1 shared
- Rozalina Grubina Mccoy1 shared
Most similar at Yale University
Same institution · by research overlap
- Holly Gwen Prigerson$25,326,202
- Harriet M Kluger$18,066,555
- James S Duncan$40,355,994
- Paul K Maciejewski$2,711,642
- David C Madoff$1,574,515
Others in their field
Top investigators on “Glycemic Control”
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$109,054,003
- Rose A Gubitosi-Klug · Case Western Reserve University$72,476,622
- Katherine M Detre · University Of Pittsburgh At Pittsburgh$33,288,043
- Alessandro Doria · Joslin Diabetes Center$22,361,865
- Barbara Halina Braffett · George Washington University$22,111,472
- Sheryl F. Kelsey · University Of Pittsburgh At Pittsburgh$22,065,571
Research focus
Glycemic ControlGlycosylated Hemoglobin ADiabetes MellitusCaringHypoglycemiaNon-Insulin-Dependent Diabetes MellitusFuturePersonsAdverse EffectsAdultInsulinClinical TrialsSuccessPharmaceutical PreparationsGuidelinesHealthcareClinical PracticeHospitalizationQuality Of LifeDiabetes ManagementLeadElderlyLifePatient Oriented
Grant awards (15)
"Insulin Affordability: Unpacking the Impact of the Inflation Reduction Act on Diabetes Outcomes in Medicare."$749,566
R01 · FY2025 · DK · contact PI
Addressing Social Determinants of Health in Young Adults with Type 1 Diabetes Through Comprehensive Assessment, Responsiveness, and Engagement (T1CARE)$512,812
R01 · FY2025 · DK · contact PI
QBSafe: a randomized trial of a novel intervention to improve care for people living with type 2 diabetes.$264,919
R01 · FY2024 · DK · contact PI
QBSafe: a randomized trial of a novel intervention to improve care for people living with type 2 diabetes.$269,641
R01 · FY2023 · DK · contact PI
Relaxed Glycemic Control and the Risk of Infections in Older Adults with Type 2 Diabetes$400,000
R56 · FY2022 · AG
QBSafe: a randomized trial of a novel intervention to improve care for people living with type 2 diabetes.$305,238
R01 · FY2022 · DK · contact PI
QBSafe: A novel approach to care for older, complex adults with type 2 diabetes$204,072
R21 · FY2020 · AG · contact PI
QBSafe: A novel approach to care for older, complex adults with type 2 diabetes$262,730
R21 · FY2019 · AG · contact PI
Predicting Severe Hypoglycemia among Older Adults with Diabetes$140,357
K23 · FY2018 · AG · contact PI
Predicting Severe Hypoglycemia among Older Adults with Diabetes$156,869
K23 · FY2017 · AG · contact PI
Predicting Severe Hypoglycemia among Older Adults with Diabetes$157,002
K23 · FY2016 · AG · contact PI
Predicting Severe Hypoglycemia among Older Adults with Diabetes$166,882
K23 · FY2015 · AG · contact PI
Predicting Severe Hypoglycemia among Older Adults with Diabetes$156,823
K23 · FY2014 · AG · contact PI
Toward personalized diabetes care: Understanding hypoglycemia in older adults$83,250
R03 · FY2014 · AG · contact PI
Toward personalized diabetes care: Understanding hypoglycemia in older adults$83,250
R03 · FY2013 · AG · contact PI